We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

80 hedge funds and large institutions have $200M invested in Avadel Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 26 increasing their positions, 16 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

309% more call options, than puts

Call options by funds: $6.67M | Put options by funds: $1.63M

63% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 16

57% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 7

5% more funds holding

Funds holding: 76 → 80 (+4)

0.09% less ownership

Funds ownership: 56% → 55.91% (-0.09%)

32% less capital invested

Capital invested by funds: $294M → $200M (-$93.9M)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
80
Holders Change
+4
Holders Change %
+5.26%
% of All Funds
1.39%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
11
Increased
26
Reduced
16
Closed
7
Calls
$6.67M
Puts
$1.63M
Net Calls
+$5.04M
Net Calls Change
+$409K

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$3.89M
2
BIP
Brandes Investment Partners
California
+$2.43M
3
WP
Woodline Partners
California
+$1.85M
4
TLP
Tri Locum Partners
New York
+$1.22M
5
Morgan Stanley
Morgan Stanley
New York
+$1.21M

Top Sellers

Rank Fund Capital Flow
1
ACP
Acuta Capital Partners
California
-$4.24M
2
BlackRock
BlackRock
New York
-$3.85M
3
ACM
Asymmetry Capital Management
California
-$2.48M
4
California Public Employees Retirement System
California Public Employees Retirement System
California
-$1.06M
5
PAMU
Pictet Asset Management (UK)
United Kingdom
-$902K
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
26
State Street
Massachusetts
$939K +$149K +18,771 +16%
EWM
27
Edge Wealth Management
New York
$881K – – –
Citadel Advisors
28
Citadel Advisors
Florida
$770K +$9.07K +1,142 +1%
KP
29
Keel Point
Alabama
$724K +$513K +64,569 +150%
AI
30
Atom Investors
Texas
$661K +$482K +60,719 +162%
IAMOG
31
Investors Asset Management of Georgia
Georgia
$422K +$56.8K +7,150 +13%
SC
32
Schulhoff & Co
Ohio
$410K – – –
HF
33
HRT Financial
New York
$377K +$338K +42,581 +315%
Bank of America
34
Bank of America
North Carolina
$376K +$115K +14,425 +35%
GCP
35
GSA Capital Partners
United Kingdom
$356K +$420K +52,933 New
CM
36
Caption Management
Oklahoma
$298K – – –
Janney Montgomery Scott
37
Janney Montgomery Scott
Pennsylvania
$278K -$39.3K -4,950 -11%
Geode Capital Management
38
Geode Capital Management
Massachusetts
$272K -$15.2K -1,917 -5%
SM
39
SG3 Management
Puerto Rico
$236K -$119K -15,000 -30%
Lazard Asset Management
40
Lazard Asset Management
New York
$235K – – –
Goldman Sachs
41
Goldman Sachs
New York
$232K +$116K +14,661 +74%
EVM
42
Eaton Vance Management
Massachusetts
$216K – – –
Mariner
43
Mariner
Kansas
$209K – – –
Squarepoint
44
Squarepoint
New York
$190K +$129K +16,194 +135%
BlackRock
45
BlackRock
New York
$165K -$3.85M -484,706 -95%
AAS
46
Avantax Advisory Services
Texas
$154K +$27.8K +3,500 +18%
DekaBank Deutsche Girozentrale
47
DekaBank Deutsche Girozentrale
Germany
$135K – – –
LPL Financial
48
LPL Financial
California
$129K +$23.8K +3,000 +19%
Commonwealth Equity Services
49
Commonwealth Equity Services
Massachusetts
$127K -$13.5K -1,700 -8%
Jane Street
50
Jane Street
New York
$117K -$491K -61,808 -78%
1
2
3 4

AVDL Hedge Fund Activity: Q2 2021 in Review

80 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q2 2021, worth a combined $200M — down 32% from $294M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new AVDL positions and 7 closed out — a net gain of 4 holders — while 26 added to existing stakes and 16 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $3.89M. The largest seller was Acuta Capital Partners, cutting an estimated $4.24M.

  • 80 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q2 2021, up from 76 in Q1 2021.
  • Funds reported $200M of Avadel Pharmaceuticals stock for Q2 2021, down 32% quarter-over-quarter.
  • 11 funds opened new Avadel Pharmaceuticals positions in Q2 2021 and 7 closed out, a net change of +4 holders.
  • The largest Avadel Pharmaceuticals buyer in Q2 2021 was Janus Henderson Group, an estimated $3.89M added.
  • The largest Avadel Pharmaceuticals seller in Q2 2021 was Acuta Capital Partners, an estimated $4.24M sold.

Based on aggregated 13F filings for Q2 2021.